Related Experiment Video
Updated: Jul 12, 2025

Author Spotlight: Evaluation of Protein-Condensate Dynamics in Live Human Cells
Published on: January 5, 2024
Modeling the protein binding non-linearity in population pharmacokinetic model of valproic acid in children with
Lina Zhang1, Maochang Liu2, Weiwei Qin3
1Department of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Insights
Population pharmacokinetic models for valproic acid in children with epilepsy show poor predictive ability. The linear non-saturable binding equation and Bayesian forecasting with prior data improved model performance.
Area of Science:
- Pharmacokinetics
- Pediatric epilepsy
- Drug metabolism
Background:
- Population pharmacokinetics (popPK) models for valproic acid (VPA) in pediatric epilepsy are established.
- The extrapolation and predictive performance of these models in diverse clinical settings remain unexamined.
Purpose of the Study:
- To evaluate the predictive capabilities of existing pediatric VPA popPK models.
- To assess the impact of different protein binding modeling strategies on VPA model performance.
Main Methods:
- Analysis of 255 trough VPA concentrations from 202 pediatric epilepsy patients.
- External validation using prediction diagnostics, simulation-based analysis, and Bayesian forecasting.
- Development and comparison of five popPK models with varied protein binding strategies.
Main Results:
- Ten VPA popPK models were identified; co-medication, body weight, dose, and age were key covariates for VPA clearance.
- The Serrano et al. model demonstrated the best predictive performance among existing models.
- All models showed inadequate simulation-based performance; the linear non-saturable binding equation and Bayesian forecasting improved predictability.
Conclusions:
- Most VPA popPK models in pediatric epilepsy exhibit unsatisfactory predictive abilities.
- The linear non-saturable binding equation is superior for modeling VPA's non-linear binding.
- Bayesian forecasting enhances model accuracy, especially with sufficient prior data.
Abstract:
Background: Several studies have investigated the population pharmacokinetics (popPK) of valproic acid (VPA) in children with epilepsy. However, the predictive performance of these models in the extrapolation to other clinical environments has not been studied. Hence, this study evaluated the predictive abilities of pediatric popPK models of VPA and identified the potential effects of protein binding modeling strategies. Methods: A dataset of 255 trough concentrations in 202 children with epilepsy was analyzed to assess the predictive performance of qualified models, following literature review. The evaluation of external predictive ability was conducted by prediction- and simulation-based diagnostics as well as Bayesian forecasting. Furthermore, five popPK models with different protein binding modeling strategies were developed to investigate the discrepancy among the one-binding site model, Langmuir equation, dose-dependent maximum effect model, linear non-saturable binding equation and the simple exponent model on model predictive ability. Results: Ten popPK models were identified in the literature. Co-medication, body weight, daily dose, and age were the four most commonly involved covariates influencing VPA clearance. The model proposed by Serrano et al. showed the best performance with a median prediction error (MDPE) of 1.40%, median absolute prediction error (MAPE) of 17.38%, and percentages of PE within 20% (F20, 55.69%) and 30% (F30, 76.47%). However, all models performed inadequately in terms of the simulation-based normalized prediction distribution error, indicating unsatisfactory normality. Bayesian forecasting enhanced predictive performance, as prior observations were available. More prior observations are needed for model predictability to reach a stable state. The linear non-saturable binding equation had a higher predictive value than other protein binding models. Conclusion: The predictive abilities of most popPK models of VPA in children with epilepsy were unsatisfactory. The linear non-saturable binding equation is more suitable for modeling non-linearity. Moreover, Bayesian forecasting with prior observations improved model fitness.
More Related Videos
07:41Modeling Fast-scan Cyclic Voltammetry Data from Electrically Stimulated Dopamine Neurotransmission Data Using QNsim1.0
Published on: June 5, 2017
11:06Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
Published on: April 7, 2023
Related Concept Videos
Nonlinear Pharmacokinetics: Bioavailability and Protein-Drug Binding
To quantify the extent of bioavailability, pharmacologists often use a parameter called .
Physiological Pharmacokinetic Models: Assumption with Protein Binding
Nonlinear Pharmacokinetics: Causes of Nonlinearity
Nonlinear drug absorption can occur when the process is rate-limited by solubility, carrier-mediated transport systems, or saturation of the presystemic gut wall or hepatic metabolism. For instance, high doses of riboflavin...
Pharmacokinetic Models: Overview
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
Nonlinear Pharmacokinetics: Overview
Nonlinearity can arise due to the saturation of plasma protein-binding or...
Analysis of Population Pharmacokinetic Data